Toggle Mobile Navigation

Archive for the ‘Regulatory Affairs’ Category

Senate Confirms New Head of FDA: Two-Time ExL Speaker Dr. Scott Gottlieb

ExL Events would like to congratulate our speaker alumnus Dr. Scott Gottlieb for the recent United States Senate confirmation, naming him the new Food and Drug Administration commissioner. Dr. Gottlieb was the keynote speaker at ExL’s 2nd Trial Design Innovation Conference and was also a featured speaker at our Private Fee-for-Service event.

President Donald Trump nominated Gottlieb earlier this year, for his previous service as deputy commissioner for the FDA, as well as his experience in the pharmaceutical and health care industries. As the FDA’s newly appointed commissioner, Gottlieb will…

READ MORE


Abuse-Deterrent Formulations Save Lives

abuse deterrence blog post quoteThis guest blog post is written by Dan Cohen. Dan is the Forum Chair of the Abuse Deterrent Coalition. For more information, go to www.abusedeterrent.org.

As we near the end of 2015, it is obvious that the prescription drug crisis identified by the White House in 2011 has gotten even more desperate and requires urgent action. An estimated 16,000 lives are lost each year due to prescription opioid abuse. That’s 46 mothers, fathers, sisters and brothers lost every single day of the year.

Prescription drug abuse is…

READ MORE


The Value of Healthcare: Examining the Rising Cost of Prescription Drugs

Specialty prescription pill costs are risingHealthcare reform has been a major topic in America the last few years. Everyone wants to see the cost of staying healthy go down, or at least become affordable. The problem is those costs consist of several different factors. Getting control of expenses becomes difficult when one factor’s price rises. Such is the case with the increasing costs of prescription drugs.

Rising costs imperil the goal of maintaining good health and create the potential for greater costs in the long run. The obstacles presented by the inability…

READ MORE


live chat software